F. J. Hollis

419 total citations
8 papers, 345 citations indexed

About

F. J. Hollis is a scholar working on Pharmacology, Molecular Biology and Epidemiology. According to data from OpenAlex, F. J. Hollis has authored 8 papers receiving a total of 345 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pharmacology, 3 papers in Molecular Biology and 3 papers in Epidemiology. Recurrent topics in F. J. Hollis's work include Pharmacogenetics and Drug Metabolism (4 papers), Herpesvirus Infections and Treatments (2 papers) and Drug Transport and Resistance Mechanisms (2 papers). F. J. Hollis is often cited by papers focused on Pharmacogenetics and Drug Metabolism (4 papers), Herpesvirus Infections and Treatments (2 papers) and Drug Transport and Resistance Mechanisms (2 papers). F. J. Hollis collaborates with scholars based in United Kingdom and United States. F. J. Hollis's co-authors include Peter J. Cox, David Ryan, A S Harris, Ann K. Miller, Hugh Cowley, Graham Allen, P. C. Shardlow, Susan Fowles, Thomas A. Brown and Ann Allen and has published in prestigious journals such as Drug Metabolism and Disposition, Xenobiotica and PubMed.

In The Last Decade

F. J. Hollis

8 papers receiving 323 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
F. J. Hollis United Kingdom	7	166	88	79	64	51	8	345
N Freiberg Germany	9	165 1.0×	60 0.7×	82 1.0×	71 1.1×	26 0.5×	10	386
Sabry Shaarawy Egypt	11	146 0.9×	125 1.4×	74 0.9×	80 1.3×	36 0.7×	22	477
Martin Perreault Canada	12	111 0.7×	90 1.0×	70 0.9×	71 1.1×	97 1.9×	21	374
Walid Karam Lebanon	12	175 1.1×	148 1.7×	97 1.2×	94 1.5×	32 0.6×	17	427
Chang-Hong Jiang China	9	122 0.7×	108 1.2×	179 2.3×	30 0.5×	30 0.6×	14	478
Jin Ah Jung South Korea	11	85 0.5×	100 1.1×	77 1.0×	48 0.8×	41 0.8×	49	409
Jennifer M. Malinowski United States	6	117 0.7×	44 0.5×	42 0.5×	37 0.6×	67 1.3×	7	337
Daniel Y. Hung Australia	13	110 0.7×	138 1.6×	113 1.4×	81 1.3×	14 0.3×	20	395
Takahiro Murai Japan	10	83 0.5×	58 0.7×	142 1.8×	29 0.5×	39 0.8×	27	354
Chester L. Bowen United States	13	224 1.3×	102 1.2×	32 0.4×	25 0.4×	39 0.8×	27	593

Countries citing papers authored by F. J. Hollis

Since Specialization

Citations

This map shows the geographic impact of F. J. Hollis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. J. Hollis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. J. Hollis more than expected).

Fields of papers citing papers by F. J. Hollis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. J. Hollis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. J. Hollis. The network helps show where F. J. Hollis may publish in the future.

Co-authorship network of co-authors of F. J. Hollis

This figure shows the co-authorship network connecting the top 25 collaborators of F. J. Hollis. A scholar is included among the top collaborators of F. J. Hollis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. J. Hollis. F. J. Hollis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Sanderson, Joseph P., et al.. (2008). Nonenzymatic Formation of a Novel Hydroxylated Sulfamethoxazole Derivative in Human Liver Microsomes: Implications for Bioanalysis of Sulfamethoxazole Metabolites. Drug Metabolism and Disposition. 36(12). 2424–2428. 6 indexed citations

2.

Shardlow, P. C., et al.. (2008). Metabolism and Disposition of Fluticasone Furoate, an Enhanced-Affinity Glucocorticoid, in Humans. Drug Metabolism and Disposition. 36(11). 2337–2344. 32 indexed citations

3.

Austin, Nigel, et al.. (2001). The disposition of gemifloxacin, a new fluoroquinolone antibiotic, in rats and dogs.. PubMed. 29(4 Pt 1). 435–42. 19 indexed citations

4.

Cox, Peter J., David Ryan, F. J. Hollis, et al.. (2000). Absorption, Disposition, and Metabolism of Rosiglitazone, a Potent Thiazolidinedione Insulin Sensitizer, in Humans. Drug Metabolism and Disposition. 28(7). 772–780. 176 indexed citations

5.

East, P. D., et al.. (1996). The fate of a thiazolidinedione antidiabetic agent in rat and dog. Xenobiotica. 26(6). 627–636. 27 indexed citations

6.

Allen, Graham, et al.. (1995). Metabolic and pharmacokinetic studies following oral administration of famciclovir to the rat and dog. Xenobiotica. 25(5). 477–490. 21 indexed citations

7.

Clarke, S. E., Nigel Austin, J. C. Bloomer, et al.. (1994). Metabolism and disposition of¹⁴C-granisetron in rat, dog and man after intravenous and oral dosing. Xenobiotica. 24(11). 1119–1131. 24 indexed citations

8.

Allen, Graham, et al.. (1994). Metabolic and pharmacokinetic studies following oral administration of¹⁴C-famciclovir to healthy subjects. Xenobiotica. 24(4). 357–368. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact